Finally, regarding the nervous system, a platform that assesses adverse drug effects using pluripotent stem cells is now being developed. To conduct such an assessment, the analysis of alterations in the gene expression of cells in the nervous system, such as neuronal cells, mesenchymal stem cells, and vascular endothelial cells derived from human ESCs in a culture dish has been proposed149.
